Globe Clotrimazole cream USP, 1%

Manufacturer
TRIFECTA PHARMACEUTICALS USA LLC | Trifecta Pharmaceuticals USA
Effective date
2026-03-01
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 01:48:17

Label at a glance#

ProductClotrimazole
Active ingredientCLOTRIMAZOLE
Label structure11 sections

Indications and uses

Cures athlete’s foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis). Relieves the itching, irritation, redness, scaling and discomfort which can accompany these conditions.

Dosage and administration

Wash the affected area and dry thoroughly. ● Apply a thin layer of this product over affected area twice daily (morning and night), or as directed by a doctor. ● Supervise children in the use of this product. ● For athlete’s foot, pay special attention to the spaces between the toes; wear well-fitting ventilated shoes, and change shoes and socks at least once daily. ● For athlete’s foot and ringworm, use daily for...

Storage and handling

store at controlled room temperature 15°-30°C (59°- 86°F) Close cap tightly after use.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Clotrimazole USP 1% w/w

Purpose

OTC - PURPOSE SECTION

Antifungal Cream

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all drugs out of the reach of children. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center right away.

Uses

INDICATIONS & USAGE SECTION

Cures athlete’s foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis). Relieves the itching, irritation, redness, scaling and discomfort which can accompany these conditions.

Warnings

WARNINGS SECTION

● Do not use on children under 2 years of age unless directed by a doctor.

● For external use only

● Avoid contact with eyes.

Stop Use and ask a Doctor

OTC - STOP USE SECTION

Irritation occurs

There is no improvement within 4 weeks (for athlete's foot or ringworm) or within 2 weeks (for jock itch).

Directions

DOSAGE & ADMINISTRATION SECTION

  • Wash the affected area and dry thoroughly.

● Apply a thin layer of this product over affected area twice daily (morning and night), or as directed by a doctor.

● Supervise children in the use of this product.

● For athlete’s foot, pay special attention to the spaces between the toes; wear well-fitting ventilated shoes, and change shoes and socks at least once daily.

● For athlete’s foot and ringworm, use daily for 4 weeks. For jock itch, use daily for 2 weeks.

● If conditions persists longer, consult a doctor.

● This product is not effective on the scalp or nails. 

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Cetamacragol 1000, Cetostearyl alcohol, mineral oil, methylparaben, propylene glycol, propylparaben, purified water, white petrolatum.

Other Information

STORAGE AND HANDLING SECTION

  • store at controlled room temperature 15°-30°C (59°- 86°F)
  • Close cap tightly after use.

Questions?

OTC - QUESTIONS SECTION

Adverse drug event call 1-888-296-9067

Dist. By Trifecta Pharmaceuticals USA™

101 NE Third Avenue, Suite 1500

Ft. Lauderdale, FL 33301, USA

Made in India

www.trifecta-pharma.com

Globe Clotrimazole Anti-Fungal Cream is not manufactured or distributed by Bayer, owners of the registered trademark Lotrimin AF.

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

clotrimazole-1oz-22-CDRclotrimazole-1oz-22-CDR

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
309367clotrimazole 1 % Topical CreamPSN5
309367clotrimazole 10 MG/ML Topical CreamSCD5
309367clotrimazole 1 % Topical CreamSY5

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CLOTRIMAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130094922042002GTIN-13: 0094922042002
EAN-13: 0094922042002
GTIN-12: 094922042002
UPC-A: 094922042002
GTIN storage (14 digits): 00094922042002
cloitrimazole-1oz-22-CDR.jpg
Data codeCode 128X001QHEII7cloitrimazole-1oz-22-CDR.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b64d2752-34ef-378a-1f4f-8bff32b0d1aeProduct name420250626
cb7783e0-feaa-7e56-fb3b-d43b6efa77c9Product name220250121
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
f5395dd2-4395-d8c6-3477-8c2d4a2f951cProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69396-087-01Clotrimazole28.4 g in 1 TUBECREAM28.45
69396-087-01Clotrimazole1 in 1 BOXCREAM15
69396-087-55Clotrimazole5 in 1 BOXCREAM55
69396-087-55Clotrimazole28.4 g in 1 TUBECREAM28.45

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69396-08769396-087-01, 69396-087-55

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ClotrimazoleCLOTRIMAZOLETRIFECTA PHARMACEUTICALS USA LLCe0a2a907-9c3a-4c4e-e053-2995a90abb912026-03-01WarningsExact identifier
ndc (package): 69396-087-55
ndc (package): 69396-087-01
ndc (product): 69396-087
ndc11 (package): 69396008701
ndc11 (package): 69396008755
spl id: 4bf9a459-7b08-9a01-e063-6294a90ac7b9
spl set id: e0a2a907-9c3a-4c4e-e053-2995a90abb91

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.